NCT05917912 — "EASE (Efficacy of ATX01 Study in Erythromelalgia)" trial site landscape

Public-registry site landscape for NCT05917912, “EASE (Efficacy of ATX01 Study in Erythromelalgia)”, a Erythromelalgia study sponsored by AlgoTherapeutix. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05917912 (registry record)
Study title	EASE (Efficacy of ATX01 Study in Erythromelalgia)
Official title	A Randomized, Double-blind, Placebo-controlled, 2-period, Crossover Study to Evaluate the Efficacy and Safety of ATX01 (Topical Amitriptyline Hydrochloride 15% w/w) in Adult Patients With Pain Due to Erythromelalgia (EM)
Sponsor	AlgoTherapeutix
Condition(s)	Erythromelalgia
Phase	PHASE2
Listed sites	2
Site countries	United States, Germany

Patient-friendly overview of this study: eichor.com/study/NCT05917912.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05917912 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →